speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing.
Rocío Castellanos-RuedaRaphaël B Di RobertoFlorian BieberichFabrice S SchlatterDarya PalianinaOanh T P NguyenEdo KapetanovicHeinz LaubliAndreas HierlemannNina KhannaSai T ReddyPublished in: Nature communications (2022)
Chimeric antigen receptors (CARs) consist of an antigen-binding region fused to intracellular signaling domains, enabling customized T cell responses against targets. Despite their major role in T cell activation, effector function and persistence, only a small set of immune signaling domains have been explored. Here we present speedingCARs, an integrated method for engineering CAR T cells via signaling domain shuffling and pooled functional screening. Leveraging the inherent modularity of natural signaling domains, we generate a library of 180 unique CAR variants genomically integrated into primary human T cells by CRISPR-Cas9. In vitro tumor cell co-culture, followed by single-cell RNA sequencing (scRNA-seq) and single-cell CAR sequencing (scCAR-seq), enables high-throughput screening for identifying several variants with tumor killing properties and T cell phenotypes markedly different from standard CARs. Mapping of the CAR scRNA-seq data onto that of tumor infiltrating lymphocytes further helps guide the selection of variants. These results thus help expand the CAR signaling domain combination space, and supports speedingCARs as a tool for the engineering of CARs for potential therapeutic development.
Keyphrases
- single cell
- rna seq
- high throughput
- crispr cas
- copy number
- genome wide
- endothelial cells
- randomized controlled trial
- immune response
- clinical trial
- dna methylation
- stem cells
- gene expression
- dendritic cells
- regulatory t cells
- study protocol
- artificial intelligence
- peripheral blood
- double blind
- data analysis
- pluripotent stem cells